Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Indacaterol

150 µg d.o. during the first 3 weeks

DRUG

Tiotropium

150 µg d.o. during 3 weeks

Trial Locations (2)

90002-090

Pavilhão Pereira Filho, Porto Alegre

Unknown

Pavilhão Pereira Filho, Porto Alegre

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Irmandade Santa Casa de Misericórdia de Porto Alegre

OTHER